2bPrecise Deepens Oncology Functionality, Introduces Automation to Identify Medication Safety Risk in Polypharmacy Patients

Summer 2021 product features customer-driven enhancements, including patient-directed family history documentation, and strengthens infrastructure for greater scalability

RALIEGH, NC – July 27, 2021 – 2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, announced it delivered advanced and innovative functionality to clients via its Summer 2021 Product Release.

With market adoption of genetic and genomic testing accelerating, 2bPrecise added new tools and features to support point-of-care decision making for providers across a wide range of clinical specialties. Primary among the enhancements are risk stratification algorithms that help providers identify patients at greatest potential risk for drug-gene interactions, specifically those taking five or more medications. New automation notifies providers if any of their patients’ medications carries pharmacogenomic (PGx) indicators and prompts them to consider pharmacogenomic testing.

“An astounding number of individuals – 20% of Americans aged 40-79 – take five or more medications,” said Assaf Halevy, CEO and founder of 2bPrecise. “This cohort is at great risk for drug-gene interactions. 2bPrecise now helps these patients’ clinicians quickly identify who should undergo PGx testing to improve medication safety and ensure patients are on the most effective drug based on their unique genetic profile.” He added that 2bPrecise’s polypharmacy risk identification also represents a logical and manageable starting point for organizations unsure of how to initiate their PGx programs or identify which patients to prioritize.

The Summer 2021 release likewise makes a beta version of the 2bPrecise Precision Timeline available to new and existing clients. Precision Timeline is an at-a-glance summary view of the patient journey, presented visually instead of in narrative form, with the ability to click into specific documents, medications and molecular results. The current version of the feature focuses on oncology, but it can also be adapted for additional clinical use cases such maternal fetal medicine and pediatrics. Displaying a cross-domain, chronological view over time, Precision Timeline enables providers to instantly comprehend the patient story without examining dozens of screens and documents in the electronic health record (EHR).

“We received enthusiastic feedback from clients about Precision Timeline,” Halevy noted. “It will save clinicians significant time as they review the patient journey over time and spanning multiple providers. Clinicians can more easily prepare for appointments and tumor board sessions. Plus, they can be more confident as they have a comprehensive view of the patient’s status and condition to support clinical decision making.”

Patient engagement and enablement are also critical components to this 2bPrecise upgrade. Patients using the FollowMyHealth® portal will be able to complete family history documentation at their own convenience, outside of office visits. The information will populate the 2bPrecise pedigree module automatically, saving genetic counselors and other clinicians significant time as they evaluate which patients are at risk for heritable diseases and should be referred for genetic testing.

Additional enhancements include user-friendly attributes of the Genomic EHR Mentor (GEM™) application that resides on the users native EHR desktop, as well as improved platform infrastructure for optimal security and performance.

About 2bPrecise

The cloud-based 2bPrecise platform consumes genetic/genomic data from molecular labs and clinical information from EHRs, synthesizing them into a clinical-genomic ontology. The 2bPrecise Genomic EHR Mentor (GEM™) brings the resulting precision medicine insights into a physician’s EHR workflow for immediate and timely use. With discrete test results consolidated into an invaluable data set, provider organizations are likewise equipped to drive efficient workflows for genomic interventions, extract population analytics, design clinical intervention programs, build cohorts for trial recruitment, enable participation in research studies and more. Learn more at www.2bPreciseHealth.com.


Media Contact:
Erica Navar
Account Executive, Social Media Manager
Aria Marketing for 2bPrecise
(909) 538-9541